Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study-Reference-Cited by-同舟云学术

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study

Published:2009-11 Issue:11 Volume:10 Page:1070-1076
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Mook Stella,Schmidt Marjanka K,Rutgers Emiel J,van de Velde Anthonie O,Visser Otto,Rutgers Sterre M,Armstrong Nicola,van't Veer Laura J,Ravdin Peter M

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. NCCN Clinical practice guidelines in oncology: breast cancer V.I.2009. http://www.nccn.org/index.asp (accessed June 2, 2009).

2. National Institutes of Health consensus development conference statement: adjuvant therapy for breast cancer, November 1–3, 2000;Eifel;J Natl Cancer Inst,2001

3. Meeting highlights: international consensus panel on the treatment of primary breast cancer;Goldhirsch;J Clin Oncol,2001

4. A prognostic index in primary breast cancer;Haybittle;Br J Cancer,1982

5. The Nottingham Prognostic Index in primary breast cancer;Galea;Breast Cancer Res Treat,1992

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current views on in vivo models for breast cancer research and related drug development;Expert Opinion on Drug Discovery;2023-12-14

2. Automated classification of breast cancer histologic grade using multiphoton microscopy and generative adversarial networks;Journal of Physics D: Applied Physics;2022-11-29

3. A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs;Frontiers in Oncology;2022-09-26

4. A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast;Breast Cancer Research and Treatment;2022-09-10

5. The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study;Annals of Surgical Oncology;2022-07-09